Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News

March 8, 2011 โ€“ Nile Therapeutics is pursuing a new indication for cenderitide, formerly CD-NP. The company is ...

Home March 08, 2011
Home
News

March 8, 2011 โ€“ The U.S. Food and Drug Administration (FDA) announced monthly liver enzyme tests are no longer ...

Home March 07, 2011
Home
News

March 7, 2011 โ€“ Massachusetts General Hospital (MGH) has granted an exclusive license to Santaris Pharma A/S for ...

Home March 07, 2011
Home
News

March 7, 2011 โ€“ Nile Therapeutics will partner with Medtronic to develop natriuretic peptide, cenderitide ...

Home March 07, 2011
Home
Technology


March 1, 2011 โ€“ The U.S. Food and Drug Administration (FDA) approved azilsartan medoxomil to treat high blood ...

Home March 01, 2011
Home
News

March 1, 2011 โ€“ A new study assessing the utility of genetic testing to determine a personalized warfarin dose ...

Home March 01, 2011
Home
News

February 24, 2011 โ€“ Upsher-Smith Laboratories, is voluntarily recalling one lot (lot #284081) of Jantoven Warfarin ...

Home February 24, 2011
Home
Feature | Dave Fornell

Clopidogrel (Plavix) has been the standard antiplatelet therapy for a decade, but it is now facing challenges with ...

Home February 18, 2011
Home
Technology

February 16, 2011 โ€“ The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous ...

Home February 16, 2011
Home
News

February 10, 2011 โ€“ A Phase 2 clinical trial has been initiated to test the safety and efficacy of drug to reverse ...

Home February 10, 2011
Home
News

January 7, 2011 โ€“ A new study from The Ohio State University found that Protandim can suppress intimal ...

Home January 07, 2011
Home
Feature

December 29, 2010 - Research on reducing risks, improving medical treatment and improving lifestyle behaviors to ...

Home December 29, 2010
Home
News

December 29, 2010 โ€“ Patient enrollment has been completed for a Phase III trial of an oral Factor Xa inhibitor ...

Home December 29, 2010
Home
Technology


December 27, 2010 โ€“ The U.S. Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and ...

Home December 27, 2010
Home
News

December 21, 2010 โ€“ A once-daily, three-in-one combination blood pressure treatment has been approved in Germany ...

Home December 21, 2010
Home
Subscribe Now